Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeNON PROFITParkinson's Foundation Invests $3.4 Million in Research Grants

Parkinson’s Foundation Invests $3.4 Million in Research Grants

The Parkinson’s Foundation today announced a $3.4 million investment across 34 research grants to advance promising Parkinson’s disease (PD) research. Grants support Parkinson’s research across a variety of disciplines for scientists who are actively studying various aspects of Parkinson’s with the hope of making life better for people with the disease and ultimately, leading to a cure.

“The Parkinson’s Foundation continues to provide these annual grant opportunities especially during the COVID-19 pandemic to ensure that PD research can successfully move forward,” said John L. Lehr, President and Chief Executive Officer of the Parkinson’s Foundation. “These research grants are critical to driving better patient outcomes and ensuring a better future for people with Parkinson’s disease.”

Parkinson’s Foundation research grants fund a diverse array of research studies that provide pre and postdoctoral researchers with training opportunities and established scientists and clinicians with the support to test innovative ideas that can lead to impactful research findings in the Parkinson’s field.

“With the support of the Parkinson’s Foundation, we hope to better understand how the nervous system functions as it relates to people with advanced Parkinson’s disease experience freezing gait, an inability to move their feet, during demanding or particularly stressful situations,” said Kevin Wilkins, Ph.D., a postdoctoral grant recipient. “We hope to develop ways to identify those at risk of developing cognitive and walking impairments as their disease progresses and provide the key to better therapies.”

This year the Foundation invested $450,000 in Impact Award programs. This award supports high-risk, high-reward projects that discover more about the biology of Parkinson’s and new treatments to people with Parkinson’s. Impact Award recipients received a maximum of $150,000 for approximately one year.

“These research grants allow us to better understand Parkinson’s disease and move the needle forward for better care and therapies for people with PD,” said James Beck, PhD, Chief Scientific Officer of the Parkinson’s Foundation. “We are thrilled to support these highly-promising grant recipients as they advance research towards a cure.”

Parkinson’s Foundation research investments are selected through a competitive application process and peer-reviewed by a panel that includes scientific experts and Foundation-trained research advocates. Since 1957, the Foundation has invested more than $365 million in Parkinson’s research and clinical care.

Research award categories include independent investigator awards, fellowships and early career awards, collaborative fellowships awards and Parkinson’s Foundation Research Centers awards. For more information about Parkinson’s Foundation research grants, visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy